JP2023516957A5 - - Google Patents
Info
- Publication number
- JP2023516957A5 JP2023516957A5 JP2022551653A JP2022551653A JP2023516957A5 JP 2023516957 A5 JP2023516957 A5 JP 2023516957A5 JP 2022551653 A JP2022551653 A JP 2022551653A JP 2022551653 A JP2022551653 A JP 2022551653A JP 2023516957 A5 JP2023516957 A5 JP 2023516957A5
- Authority
- JP
- Japan
- Prior art keywords
- daptomycin
- excipient
- solid
- reconstitution time
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025120933A JP2025142200A (ja) | 2020-02-28 | 2025-07-18 | ダプトマイシン製剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062982945P | 2020-02-28 | 2020-02-28 | |
| US62/982,945 | 2020-02-28 | ||
| PCT/EP2021/054841 WO2021170807A1 (en) | 2020-02-28 | 2021-02-26 | Daptomycin formulation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120933A Division JP2025142200A (ja) | 2020-02-28 | 2025-07-18 | ダプトマイシン製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023516957A JP2023516957A (ja) | 2023-04-21 |
| JP2023516957A5 true JP2023516957A5 (cg-RX-API-DMAC7.html) | 2023-12-07 |
Family
ID=74797935
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022551653A Pending JP2023516957A (ja) | 2020-02-28 | 2021-02-26 | ダプトマイシン製剤 |
| JP2025120933A Pending JP2025142200A (ja) | 2020-02-28 | 2025-07-18 | ダプトマイシン製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120933A Pending JP2025142200A (ja) | 2020-02-28 | 2025-07-18 | ダプトマイシン製剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12629337B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4110303A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023516957A (cg-RX-API-DMAC7.html) |
| CN (2) | CN118873500A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021227095B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022015571A2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022010378A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021170807A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202208343B (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11759497B2 (en) | 2017-08-31 | 2023-09-19 | Xellia Pharmaceuticals Aps | Daptomycin formulations |
| EP4110303A1 (en) | 2020-02-28 | 2023-01-04 | Xellia Pharmaceuticals ApS | Daptomycin formulation |
| WO2026111848A1 (en) * | 2024-11-21 | 2026-05-28 | MAIA Pharmaceuticals, Inc. | Daptomycin compositions |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4885243A (en) | 1984-10-09 | 1989-12-05 | Eli Lilly And Company | Process for producing A-21978C derivatives |
| EP0852951A1 (de) | 1996-11-19 | 1998-07-15 | Roche Diagnostics GmbH | Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern |
| AU2001267011B2 (en) | 2000-06-21 | 2006-02-02 | Cubist Pharmaceuticals, Inc. | Compositions and methods to improve the oral absorption of antimicrobial agents |
| JP2003055256A (ja) * | 2001-08-10 | 2003-02-26 | Nihon Pharmaceutical Co Ltd | 安定な血液凝固第xiii因子製剤 |
| CA2781666C (en) | 2009-11-23 | 2017-02-21 | Cubist Pharmaceuticals, Inc. | Lipopeptide compositions and related methods |
| US20110124551A1 (en) | 2009-11-23 | 2011-05-26 | Eagle Pharmaceuticals, Inc. | Formulations of daptomycin |
| WO2013103801A1 (en) | 2012-01-04 | 2013-07-11 | Hospira, Inc. | Pharmaceutical spray drying |
| NO2887953T3 (cg-RX-API-DMAC7.html) | 2012-08-23 | 2018-03-10 | ||
| PL4066849T3 (pl) | 2012-09-11 | 2025-06-16 | Hospira Australia Pty Ltd | Preparaty daptomycyny i ich zastosowania |
| WO2016098009A1 (en) | 2014-12-16 | 2016-06-23 | Dr. Reddy’S Laboratories Limited | Lyophilized injectable compositions of daptomycin |
| CN106943587B (zh) | 2016-01-06 | 2021-06-22 | 山东新时代药业有限公司 | 一种注射用达托霉素冻干粉针及其制备工艺 |
| US11759497B2 (en) * | 2017-08-31 | 2023-09-19 | Xellia Pharmaceuticals Aps | Daptomycin formulations |
| GB201718888D0 (en) * | 2017-11-15 | 2017-12-27 | Ucb Biopharma Sprl | Method |
| EP4110303A1 (en) | 2020-02-28 | 2023-01-04 | Xellia Pharmaceuticals ApS | Daptomycin formulation |
-
2021
- 2021-02-26 EP EP21708627.1A patent/EP4110303A1/en active Pending
- 2021-02-26 WO PCT/EP2021/054841 patent/WO2021170807A1/en not_active Ceased
- 2021-02-26 CN CN202410944805.5A patent/CN118873500A/zh active Pending
- 2021-02-26 CN CN202180011662.7A patent/CN115038431B/zh active Active
- 2021-02-26 MX MX2022010378A patent/MX2022010378A/es unknown
- 2021-02-26 JP JP2022551653A patent/JP2023516957A/ja active Pending
- 2021-02-26 US US17/794,734 patent/US12629337B2/en active Active
- 2021-02-26 AU AU2021227095A patent/AU2021227095B2/en active Active
- 2021-02-26 BR BR112022015571A patent/BR112022015571A2/pt unknown
-
2022
- 2022-07-26 ZA ZA2022/08343A patent/ZA202208343B/en unknown
-
2025
- 2025-07-18 JP JP2025120933A patent/JP2025142200A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4612923B2 (ja) | 安定化された4−アミノ−3−置換−ブタン酸誘導体含有製剤およびその製造法 | |
| CN102202688B (zh) | 稳定、干燥的轮状病毒疫苗、其组合物和制备其的方法 | |
| JP2021521159A5 (cg-RX-API-DMAC7.html) | ||
| JP2020530845A5 (cg-RX-API-DMAC7.html) | ||
| WO2012043696A1 (ja) | 6-フルオロ-3-ヒドロキシ-2-ピラジンカルボキサミドのメグルミン塩 | |
| JP2020502183A5 (cg-RX-API-DMAC7.html) | ||
| CN110062620A (zh) | 液体药物组合物 | |
| WO2020001203A1 (zh) | 一种复方氨基酸维生素注射液及其应用 | |
| US20170189528A1 (en) | Stable aqueous adalimumab formulation | |
| JP2025142200A (ja) | ダプトマイシン製剤 | |
| CN113811290A (zh) | 达托霉素水性制剂 | |
| TWI791717B (zh) | 冷凍乾燥製劑之製造方法 | |
| TW202017588A (zh) | Hgf冷凍乾燥製劑 | |
| TW201538155A (zh) | 活性成份輔助組成物及將活性成份化合物遞送給對象之方法 | |
| JPS61247354A (ja) | 栄養素組成物 | |
| IL311344A (en) | Preparations and methods for the treatment of synoclinopathies | |
| JP2024520526A5 (cg-RX-API-DMAC7.html) | ||
| WO2018003946A1 (ja) | 凍結乾燥製剤の製造方法 | |
| RU2016121401A (ru) | Устойчивые при хранении лиофилизованные составы трипептидов | |
| JP2025533238A (ja) | 液体ダルババンシン組成物 | |
| CA3139341A1 (en) | Stable albuvirtide compositions | |
| RU2018113706A (ru) | Стабильные высококонцентрированные водные композиции ранибизумаба с пролонгированным действием при интравитреальном введении для медицинского применения | |
| JPWO2004028557A1 (ja) | 安定化されたタンパク組成物 | |
| KR102692727B1 (ko) | 수성 제제 및 주사기 내 수성 제제, 및 항체 단백질 탈응집제 및 항체 단백질 탈응집 방법 | |
| WO2020055360A2 (en) | The parenteral composition comprising carfilzomib |